Stories about Glucose
- more
Roche teams up with Diabeloop to advance the management of insulin pump therapy
moreFORA® 6 Blood Glucose Monitors Help Diabetic Patients Monitor COVID-19 Risks
moreAscensia Diabetes Care; PHC Holdings Corporation
PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics
moreInvestigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial
moreSwitching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice
moreTechnische Universität München
Improving immunotherapy for cancer
moreBeta cells from stem cells: Potential for cell replacement therapy
moreAutonomous Thermometer System Launched to Assist in COVID-19 Pandemic
moreAveritas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin) 8% Patch for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
moreForaCare Suisse AG Launches "Lab in the Pocket" Technology
moreDiscovery of potential novel therapeutic target for non-alcoholic fatty liver disease
moreTresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes
moreTechnische Universität München
Dry feed for superfood producers: study investigates nutritional behavior of insects
moreDiabeloop and ViCentra Announce European Distribution Partnership
moreForaCare Suisse AG Distributor, AlphaDiab, Ranked One of the Fastest Growing Companies in France
moreMerck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
moreForaCare Suisse AG forms service-oriented partnership with B. Braun
moreTwo-pronged approach - Novel combined therapy tackles excess fatty tissue
moreInternational Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event
moreBAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study
more
1